Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Pathology

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64968-1PMID 10702416PMCID PMC1876832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat

  2004cited by this paper
• Pituitary and testicular function in growth hormone receptor gene knockout mice.

  1999cited by this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cited by this paper
• Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice.

  1997cited by this paper
• Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat.

  1997cited by this paper
• A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

  1997cited by this paper
• Central Administration of a Growth Hormone (GH) Receptor mRNA Antisense Increases GH Pulsatility and Decreases Hypothalamic Somatostatin Expression in Rats

  1996cited by this paper
• The ontogeny of pit-1 expression in the human fetal pituitary gland.

  1996cited by this paper
• Hypothalamic GH receptor gene expression in the rat: effects of altered GH status.

  1995cited by this paper
• In vitro and in vivo studies of antagonistic effects of human growth hormone analogs.

  1994cited by this paper
• Pituitary adenomas in mice transgenic for growth hormone-releasing hormone.

  1992cited by this paper
• Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice.

  1991cited by this paper
• Glycine 119 of bovine growth hormone is critical for growth-promoting activity.

  1991cited by this paper
• Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.

  1991cited by this paper
• Tumors of the Pituitary Gland

  1990cited by this paper
• Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study

  1990cited by this paper
• Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.

  1990cited by this paper
• Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation

  1989cited by this paper
• Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation.

  1989cited by this paper
• Failure of growth hormone (GH) to feed back at the level of the pituitary to alter the response of the somatotrophs to GH-releasing factor.

  1988cited by this paper
• Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations.

  1988cited by this paper
• Human fetal adenohypophysis. Electron microscopic and ultrastructural immunocytochemical analysis.

  1988cited by this paper
• GROWTH HORMONE PRETREATMENT IN MAN BLOCKS THE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE; EVIDENCE FOR A DIRECT EFFECT OF GROWTH HORMONE

  1987cited by this paper
• Human Fetal Adenohypophysis

  1986cited by this paper
• Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH.

  1986cited by this paper
• Isolated growth hormone deficiency: immunocytochemistry.

  1984cited by this paper
• Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.

  1984cited by this paper
• Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

  1982influential reference
• Armed Forces Institute of Pathology.

  1968cited by this paper

• Structural and proteomic repercussions of growth hormone receptor deficiency on the pituitary gland: Lessons from a translational pig model

  2023cites this paper
• Growth hormone receptor antagonism downregulates ATP-binding cassette transporters contributing to improved drug efficacy against melanoma and hepatocarcinoma in vivo

  2022cites this paper
• Cell Networks in Endocrine/Neuroendocrine Gland Function.

  2022cites this paper
• Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

  2021cites this paper
• Mice with gene alterations in the GH and IGF family

  2021influential citation
• Pathology of pituitary growth hormone excess

  2021cites this paper
• Molecular Predictors of Clinical Behavior in Pituitary Adenohypophysial Tumors

  2019cites this paper
• Generation and characterization of a pig model for Laron syndrome

  2018cites this paper
• Growth hormone in the brain

  2017cites this paper
• Growth Hormone and the Epithelial-to-Mesenchymal Transition

  2017cites this paper
• Genetic Predictors of Response to Different Medical Therapies in Acromegaly.

  2016cites this paper
• Update on prognostic factors in acromegaly: Is a risk score possible?

  2015cites this paper
• Capítulo 9 – Farmacogenómica de la acromegalia

  2015cites this paper
• Genetic dissection of IGF1-dependent and -independent effects of permanent GH excess on postnatal growth and organ pathology of mice.

  2014cites this paper
• Growth Hormone and Anabolic Androgenic Steroids : Effects on Neurochemistry and Cognition

  2013cites this paper
• Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes

  2013cites this paper
• Biomarkers of aggressive pituitary adenomas.

  2012cites this paper
• Clinical implications of growth hormone–secreting tumor subtypes

  2012cites this paper
• Sexual dimorphism of growth hormone in the hypothalamus: regulation by estradiol.

  2012cites this paper
• Cellular and molecular specificity of pituitary gland physiology.

  2012cites this paper
• Resistance to somatostatin analogs in acromegaly.

  2011influential citation
• Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse.

  2011cites this paper
• GHR Knockout and the CNS

  2011cites this paper
• The Laron Mouse

  2011cites this paper
• In vitro characterization of human growth hormone mutants

  2011cites this paper
• Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study.

  2010cites this paper
• The pathogenesis of pituitary tumors.

  2009cites this paper
• Kisspeptin, a Novel Hypothalamic Regulator of the Somatotropic and Gonadotropic Axes in Ruminants

  2009cites this paper
• Understanding the Multifactorial Control of Growth Hormone Release by Somatotropes

  2009cites this paper
• A Proteomic Approach to Identify Biomarkers for Growth Hormone and Aging

  2009cites this paper
• Endocrine effects of growth hormone overexpression in transgenic coho salmon.

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) The TSH receptor in the pituitary and its clinical relevance

  2007cites this paper
• A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.

  2007cites this paper
• 2 2 Expressionn of the Thyroid Stimulating Hormone Receptorr in the Folliculo-Stellate Cells oF the Human Anteriorr Pituitary

  2007cites this paper
• An essential role for the hematopoietic transcription factor Ikaros in hypothalamic–pituitary-mediated somatic growth

  2006cites this paper
• Feedback regulation of growth hormone synthesis and secretion in fish and the emerging concept of intrapituitary feedback loop.

  2006cites this paper
• Mechanisms of Disease: the pathogenesis of pituitary tumors

  2006cites this paper
• Expression of growth hormone and its receptor in the lungs of embryonic chicks

  2005cites this paper
• cDNA microarray reveals signaling pathways involved in hormones expression of human pituitary.

  2005cites this paper
• Communications in Genomics and Proteomics cDNA microarray reveals signaling pathways involved in hormones expression of human pituitary q

  2005cites this paper
• Ikaros integrates endocrine and immune system development.

  2005cites this paper
• Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice.

  2004cites this paper
• Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.

  2004cites this paper
• Medical Management of Pituitary Adenomas: Structural and Ultrastructural Changes

  2004cites this paper
• Ultra Short-Loop Feedback Control of Thyrotropin Secretion

  2004cites this paper
• Role of regulatory factors in pituitary tumour formation.

  2004cites this paper
• Novel Aspects of Growth Hormone Autoregulation: Growth Hormone-Induced Growth Hormone Gene Expression in Grass Carp Pituitary Cells through Autocrine/Paracrine Mechanisms.

  2004cites this paper
• Novel aspects of growth hormone (GH) autoregulation: GH-induced GH gene expression in grass carp pituitary cells through autocrine/paracrine mechanisms.

  2004cites this paper
• Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor

  2003cites this paper
• Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.

  2003cites this paper
• Growth hormone-induced diacylglycerol and ceramide formation via Galpha i3 and Gbeta gamma in GH4 pituitary cells. Potentiation by dopamine-D2 receptor activation.

  2002cites this paper
• Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary.

  2002cites this paper
• Prolonged gastrointestinal transit in a patient with a glucagon-like peptide (GLP)-1- and -2-producing neuroendocrine tumor.

  2002cites this paper
• Growth Hormone-induced Diacylglycerol and Ceramide Formation via Gαi3 and Gβγ in GH4 Pituitary Cells

  2002cites this paper
• Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro.

  2002cites this paper
• The pathogenesis of pituitary tumours

  2002cites this paper
• Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b).

  2002cites this paper
• Converting a differentiation cascade into longitudinal growth: stereology and analysis of transgenic animals as tools for understanding growth plate function

  2001cites this paper
• Mutation in the Neural Cell Adhesion Molecule Interferes with the Differentiation of Anterior Pituitary Secretory Cells

  2001cites this paper
• The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.

  2001cites this paper
• Growth hormone receptor/binding protein (GHR/BP) knockout mice: a 3-year update.

  2001cites this paper
• The place of pegvisomant in the management of acromegaly

  2001cites this paper
• Transgenic and Knockout Mouse Models Clarify Pituitary Development, Function and Disease

  2001cites this paper
• Expression of the thyroid-stimulating hormone receptor in the folliculo-stellate cells of the human anterior pituitary.

  2000cites this paper
• Responsiveness of Irradiated Rat Anterior Pituitary Cells to Hypothalamic Releasing Hormones Is Restored by Treatment with Growth Hormone

  2000cites this paper
• Acta Universitatis Upsaliensis Uppsala 2013

  year unknowncites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Gh in the Central Nervous System: Lessons from the Growth Hormone Receptor Knockout Mouse

  year unknowncites this paper
• Acta Universitatis Upsaliensis Uppsala 2012

  year unknowncites this paper